Repetitive Thinking in Fibromyalgia
CompletedNot applicableNCT03964285
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Some fibromyalgia patients may use inappropriate emotional regulation strategies to respond to pain. Rumination could be one of this inefficient regulation strategies. The investigators believe that the use of rumination strategies to respond to the discomfort of daily physical activity would maintain and aggravate a negative emotional state after the effort. Distraction would be a more effective strategy to cope with pain. From this data, the investigators want to explore the causal link between rumination and negative affectivity after physical activity in fibromyalgia using an experimental design.
Study details
- Official title
- Impact of Rumination on Affectivity After Physical Activity in Fibromyalgia
- Conditions
- Rumination
- Fibromyalgia
- Chronic Pain
- Repetitive Negative Thinking
- Interventions
- Other: rumination induction
- Other: distraction induction
- Sponsor
- Centre Hospitalier Universitaire, Amiens
- Collaborators
- Université de Lille
- Start date
- 2019-02-26
- Primary completion
- 2020-02-25
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- France
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Adults Patients * Free and informed consent signed. * French native speaker, writer and reader. * according 1990 American College of Rheumatology criteria : Patients with diffuse pain for more than three months and with digital palpation pain on more than 11 insertion points. Exclusion Criteria: * minor patients * Adult major under administrative protection * Patient with severe psychosis or depression or severe anxiety or impulsivity as assessed by the clinician
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03964285